{
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "document": "CDC_Influenza_vaccines",
  "verification_stats": {
    "total_extracted": 1,
    "verified": 0,
    "rejected": 1,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": 1,
      "quote": "Flublok Quadrivalent (RIV4) was evaluated in a pivotal clinical efficacy trial against a U.S.-licensed standard-dose, egg-based quadrivalent inactivated influenza vaccine (IIV4; Fluarix Quadrivalent, GSK).",
      "reason": "not found",
      "original_explanation": "This quote directly states that Flublok Quadrivalent was evaluated in a pivotal trial against Fluarix Quadrivalent, which is a standard-dose quadrivalent influenza vaccine, thus supporting the claim."
    }
  ],
  "model_used": "gpt-4.1"
}